Featured Strain of the Month: Royal Purple...

Dear Patients,

We are excited to announce that one of our most popular Indica Dominant Strains, Royal Purple Kush (19% THC, 0.4% CBD), is now available for only $9.00 per gram!

For information on other CannTrust™ products please click here or call a Customer Care Team Member at 1-855-794-2266. As new Indica and Sativa dominant strains and products become available, we will continue to keep you informed.

Thank you for choosing CannTrust™ as your trusted supplier of quality medical cannabis.

* The release and price of this product is subject to change at any time without notice.


CannTrust Customer Care Team

Phone: 1-855-794-2266 (Monday to Friday, 8 am to 9 pm excluding holidays)
E-mail: professionalservices@canntrust.ca

To keep up to date on what is happening at CannTrust™, check the News section at www.canntrust.ca and follow us on Social Media.

About CannTrust

A federally regulated licensed producer, CannTrust™ brings more than 40 years of pharmacy and healthcare experience to the Medical Cannabis industry and applies this expertise to produce quality pharmaceutical-grade Medical Cannabis for patients in need. CannTrust™ is committed to research and innovation, to contributing to the growing body of evidence-based research regarding the use and efficacy of cannabis and to developing novel mechanisms that will make it easier for certain patients to take Medical Cannabis. The company supports ongoing patient education about Medical Cannabis, and has launched a compassionate use program to support patients with financial needs.

  • Our state-of-the-art facility provides pharmaceutical quality assurance and control combined with a patient centric approach to ensure we are producing quality products and delivering quality service to our customers.
  • Our 40,000 square foot state-of-the-art hydroponic facility provides continuous production of Medical Cannabis to address our patients’ needs.
  • We have built our own laboratory with advanced technology and equipment for testing and research on the medical use of cannabis.
By | 2017-11-09T19:52:45+00:00 March 22nd, 2017|Industry News, Product News, Second Home|0 Comments